Evaluation of the Stability of Sulfur Volatile Compounds From Exhaled Air for Halitosis Diagnosis
HALITOSIX
1 other identifier
interventional
100
1 country
1
Brief Summary
Halitosis or bad breath is a problem affecting 30% of the world's population. There are many causes, and oral pathologies, including periodontitis, are the main etiology. In order to make a diagnosis, a clinical interview is necessary to distinguish true halitosis from psychological halitosis. In addition, a measurement of volatile sulfur compounds (VSC), the main molecules involved in bad breath, is necessary. This is done during the consultation by measuring the concentration of VSCs in exhaled air. However, few private practices or hospitals have the necessary equipment to measure VSC. As a result, patients are often obliged to travel long distances to obtain a consultation including this specific VSC analysis. The aim of this study is to evaluate the stability of VSC values obtained in gaseous samples up to 7 days after sampling, in order to assess the clinical relevance of analyzing samples at a distance from sampling. The clinical aim is to determine whether self-sampling by the patient at home and extemporaneous analysis could be considered in the diagnosis of halitosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedAugust 6, 2025
August 1, 2025
11 months
June 24, 2024
August 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
H2S measurement
Analysis will be made at Day 0 and Day 7
Interventions
the subject is asked to aspirate the gaseous contents of his oral cavity using a 1ml plastic syringe.
Eligibility Criteria
You may qualify if:
- Adult, male or female
- Subject affiliated with a social health insurance plan
- Able to understand the objectives and risks of the research and to give dated and signed informed consent
- Subject presenting for consultation for diagnosis and treatment of periodontal pathology
You may not qualify if:
- Subject under safeguard of justice
- Subject under guardianship or curatorship
- Pregnancy or breast-feeding
- Impossibility of giving the subject informed information (subject in emergency situation, difficulties in understanding the subject, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinique dentaire
Strasbourg, 67000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2024
First Posted
July 3, 2024
Study Start
October 1, 2024
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
August 6, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share